| Literature DB >> 33343797 |
Shraddha Bajaria1, Ramadhani Abdul2.
Abstract
INTRODUCTION: the increased demands of health facilities and workers due to coronavirus overwhelm the already burdened Tanzanian health systems. This study evaluates the current capacity of facilities and providers for HIV care and treatment services and their preparedness to adhere to the national and global precaution guidelines for HIV service providers and patients.Entities:
Keywords: COVID-19; HIV; Tanzania; health system
Mesh:
Substances:
Year: 2020 PMID: 33343797 PMCID: PMC7733350 DOI: 10.11604/pamj.supp.2020.37.18.25443
Source DB: PubMed Journal: Pan Afr Med J
details of the facility and provider variables included in this study
| Facility variables |
|---|
|
|
| Capacity to conduct HIV testing, either by rapid diagnostic test or ELISA |
| An unexpired HIV rapid diagnostic test kit any other testing option is available in the facility the day of survey |
|
|
| treatment for any opportunistic infection or for symptoms related to HIV |
| Systematic intravenous treatment for specific fungal infections |
| Treatment of Kaposi's sarcoma |
| Palliative care such as symptom or pain management |
| Nutritional and supplementation services |
| Care for pediatric HIV patients |
| Preventive treatment for TB |
| Primary preventive treatment for opportunistic infections |
| Provision of condoms and family planning services |
|
|
| Prescription of ARV |
| Clinical follow up on clients on ARV |
| Outreach ARV facilities |
|
|
| Nucleoside reverse transcriptase inhibitors (NRTI) |
| Non-nucleoside reverse transcriptase inhibitors (NNRTI) |
| Protease inhibitors |
| Fusion inhibitor or combined ARVs |
|
|
|
|
| Counseling related to HIV testing |
| Conducting HIV testing |
| Services related to prevention of mother to child transmission (PMTCT) |
| Palliative care services |
| Any ART services, including prescription, counseling and follow up |
| Preventive treatment for opportunistic infections |
| Pediatric AIDS care |
| Post-exposure prophylaxis (PEP) |
|
|
| HIV testing and counseling |
| Infant feeding counseling |
| Nutritional counseling for HIV positive women and their infants |
| Family planning counseling for HIV positive women |
Figure 1distribution of HIV services by geographical zones
Figure 2A) qualifications of health providers at private facilities; B) qualifications of health providers at public facilities
Figure 3distribution of specific PMTCT services by facilities managing authority
proportions of available COVID-19 prevention commodities and HIV services at urban facilities by managing authority
| Overall | Public | Private | p-value | ||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| ||
|
| |||||||
|
| |||||||
|
| |||||||
| Medical masks | 124 | (28.7) | 50 | (23.5) | 74 | (33.8) | 0.018 |
| Gloves | 370 | (85.7) | 187 | (87.8) | 183 | (83.6) | 0.210 |
|
| |||||||
| Medical masks | 128 | (34.1) | 69 | (36.5) | 59 | (31.7) | 0.328 |
| Gloves | 362 | (96.5) | 183 | (96.8) | 179 | (96.2) | 0.755 |
|
| |||||||
|
| |||||||
| Running water | 373 | (86.3) | 175 | (82.2) | 198 | (90.4) | 0.013 |
| Soap | 352 | (81.5) | 163 | (76.5) | 189 | (86.3) | 0.009 |
| Alcohol based hand-rub | 145 | (33.6) | 63 | (29.6) | 82 | (37.4) | 0.083 |
| Disinfectant | 276 | (63.9) | 133 | (62.4) | 143 | (65.3) | 0.537 |
|
| |||||||
| Running water | 361 | (96.3) | 180 | (95.2) | 181 | (97.3) | 0.290 |
| Soap | 353 | (94.1) | 175 | (92.6) | 178 | (95.7) | 0.201 |
| Alcohol based hand-rub | 138 | (36.8) | 75 | (39.7) | 63 | (33.9) | 0.243 |
| Disinfectant | 308 | (82.1) | 156 | (82.5) | 152 | (81.7) | 0.836 |
|
| |||||||
| Any NRTI | 166 | (68.9) | 124 | (72.5) | 42 | (60.0) | 0.057 |
| Any NNRTI | 218 | (90.5) | 158 | (92.4) | 60 | (85.7) | 0.109 |
| Any protease inhibitors | 88 | (36.5) | 65 | (38.0) | 23 | (32.9) | 0.451 |
| Any combination ARV drug | 224 | (92.9) | 162 | (94.7) | 62 | (88.6) | 0.090 |
|
| |||||||
| HIV testing site | 234 | (66.7) | 163 | (79.5) | 71 | (48.6) | 0.000 |
| HIV care and support site | 183 | (75.6) | 146 | (86.9) | 37 | (50.0) | 0.000 |
|
| |||||||
|
| 277 | (64.0) | 128 | (60.1) | 149 | (68.0) | 0.085 |
| Functioning landline | 157 | (36.3) | 69 | (32.4) | 88 | (40.2) | 0.092 |
| Functioning cellphone | 230 | (53.2) | 111 | (52.1) | 119 | (54.3) | 0.643 |
| Functioning computer | 282 | (65.3) | 155 | (72.8) | 127 | (57.9) | 0.001 |
| Access to email | 215 | (49.8) | 111 | (52.1) | 104 | (47.5) | 0.337 |
|
| 0.000 | ||||||
| HIV test counseling and 1 other service | 324 | (15.3) | 216 | (14.3) | 108 | (17.7) | |
| HIV test counseling and 2 other services | 548 | (25.8) | 392 | (25.9) | 156 | (25.6) | |
| HIV test counseling and 3 or more other services | 1151 | (54.2) | 862 | (56.9) | 289 | (47.5) | |
|
| 659 | (86.4) | 412 | (95.2) | 247 | (74.9) | 0.000 |
proportions of available COVID-19 prevention commodities and HIV services at rural facilities by managing authority
| Overall | Public | Private | p-value | ||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| ||
|
| |||||||
|
| |||||||
|
| |||||||
| Medical masks | 102 | (13.5) | 59 | (10.1) | 43 | (25.4) | 0.000 |
| Gloves | 604 | (79.9) | 465 | (79.2) | 139 | (82.3) | 0.386 |
|
| |||||||
| Medical masks | 115 | (24.7) | 54 | (16.9) | 61 | (41.8) | 0.000 |
| Gloves | 443 | (95.1) | 303 | (94.7) | 140 | (95.9) | 0.578 |
|
| |||||||
|
| |||||||
| Running water | 517 | (68.4) | 363 | (61.8) | 154 | (91.1) | 0.000 |
| Soap | 498 | (65.9) | 351 | (59.8) | 147 | (86.9) | 0.000 |
| Alcohol based hand-rub | 174 | (23.0) | 110 | (18.7) | 64 | (37.9) | 0.000 |
| Disinfectant | 432 | (57.1) | 323 | (55.0) | 109 | (64.5) | 0.028 |
|
| |||||||
| Running water | 406 | (87.1) | 267 | (83.4) | 139 | (95.2) | 0.000 |
| Soap | 396 | (84.9) | 260 | (81.3) | 136 | (93.2) | 0.001 |
| Alcohol based hand-rub | 167 | (35.8) | 94 | (29.4) | 73 | (50.0) | 0.000 |
| Disinfectant | 350 | (75.1) | 228 | (71.3) | 122 | (83.6) | 0.004 |
|
| |||||||
| Any NRTI | 171 | (45.4) | 110 | (39.6) | 61 | (61.6) | 0.000 |
| Any NNRTI | 341 | (90.5) | 247 | (88.9) | 94 | (94.9) | 0.076 |
| Any protease inhibitors | 65 | (17.2) | 34 | (12.2) | 31 | (31.3) | 0.000 |
| Any combination ARV drug | 348 | (92.3) | 254 | (91.4) | 94 | (94.9) | 0.251 |
|
| |||||||
| HIV testing site | 463 | (63.4) | 404 | (70.6) | 59 | (37.3) | 0.000 |
| HIV care and support site | 290 | (67.9) | 246 | (76.9) | 44 | (41.1) | 0.000 |
|
| |||||||
|
| 249 | (32.9) | 152 | (25.9) | 97 | (57.4) | 0.000 |
| Functioning landline | 39 | (5.2) | 9 | (1.53) | 30 | (17.8) | 0.000 |
| Functioning cellphone | 226 | (29.9) | 139 | (23.7) | 87 | (51.5) | 0.000 |
| Functioning computer | 262 | (34.7) | 152 | (25.9) | 110 | (65.1) | 0.000 |
| Access to email | 150 | (19.8) | 68 | (11.6) | 82 | (48.5) | 0.000 |
|
| 0.000 | ||||||
| HIV test counseling and 1 other service | 281 | (10.8) | 180 | (10.0) | 101 | (12.4) | |
| HIV test counseling and 2 other services | 850 | (32.6) | 627 | (34.9) | 223 | (27.5) | |
| HIV test counseling and 3 or more other services | 1397 | (53.6) | 958 | (53.3) | 439 | (54.1) | |
|
| 779 | (94.2) | 556 | (95.2) | 223 | (91.8) | 0.054 |
Figure 4A) availability of COVID-19 prevention products at facilities in urban area; B) availability of COVID-19 prevention products at facilities in rural area